ARCHIVES

Two-Drug Combination Extends Survival Of Mesothelioma

This article is from The Cancer Letter archive.

Vol. 25 No. 5 | May 31, 2002

Download PDF Visit The Full Archive

Related Articles

DSMB Recommends Discontinuing Phase III Perifosine Combination Trial

March 29, 2013

MDV3100 Improves Survival, Reduces Death Risk by 37%

November 25, 2011

Beth Israel Suspends Enrollment In Trials Following An Audit

October 22, 2010

Study Finds More Deaths On Aranesp Arm In Cancer Anemia Study, No Benefit Seen.

February 2, 2007

Petition Filed To Revoke NlH License To Use Radioactive Materials

October 20, 1995

In Brief: Sundwall Leaves Hatch to head HRSA; Terry Joins Damon Biotech; Irlin On Hunger Strike

September 12, 1986